UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

 

For the Month of April 2019

 

333-206723

(Commission File Number)

 

P.V. Nano Cell Ltd.

(Exact name of Registrant as specified in its charter)

 

8 Hamasger Street

Migdal Ha’Emek, Israel 2310102

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover

Form 20-F or Form 40-F.

 

Form 20-F þ   Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1): ____

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): ____

 

 

 

 

 

On April 22nd, 2019, P.V. Nano Cell Ltd. (the “Issuer”) issued a press release announcing signing Agreement with Allen Woods & Associates for U.S. Sales and Distribution. Exhibit 99.1 and is incorporated herein by reference.

 

Exhibit Index

 

Exhibit No.  Description
99.1  2019-04-22_PV_Nano_Cell_Sign_Agreement_with_Allen_Woods_46

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  P.V. Nano Cell Ltd.
   
Date April 26th, 2019 By:  /s/ Dr. Fernando de la Vega
    Name: Dr. Fernando de la Vega
Title: Chief Executive Officer

 

 

2